Research Report on Dental Syringes Market Globally strategic overview

The Technological advancements in dental syringes, growth in geriatric population and government legislations to avoid needlestick injuries are adding to the growth prospects of this market.

Emerging markets (such as India, China, Brazil, and Mexico) offer significant growth opportunities for players operating in the dental syringes market. The growth of the market in these regions can be attributed to factors such as rising geriatric population, rising awareness among healthcare professionals related to needlestick injuries, and ongoing government initiatives to modernize & expand healthcare infrastructure.

Expected Revenue Surge: The Dental Syringes Market is expected to reach USD 126.9 Million, at a CAGR of 5.2% during the forecast period

Objectives of the Study;

  • To define, describe, and forecast the global market on the basis of product, type, material, and region
  • To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market with respect to four main regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=42523876

dental-syringe-market1

Market Segmentation in Detailed:

Based on Product;

Categorized into three segments, namely, non-disposable syringes, disposable syringes, and safety syringes. The non-disposable syringes segment is expected to dominate the dental syringes market in 2016 mainly due to the growing number of endodontic & periodontic procedures across the globe, significant adoption of non-disposable syringes among dental professionals for administering anesthesia, and greater affordability of these products due to their reusable nature.

Based on Type,

Segmented into two segments, namely, aspirating syringes, and non-aspirating syringes. The aspirating syringes segment is expected to dominate the dental syringes market during the forecast period. The prominent market position of the aspirating syringes segment can be primarily attributed to the procedural benefits offered by aspirating syringes over conventional syringes (such as easy syringe handling, minimal operational stress, and better operational control), and longer shelf life of metallic syringes (as compared to conventional plastic syringes).

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=42523876

Geographically;

Segmented into four regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World. The Asia-Pacific market is expected to grow at the highest CAGR during the forecast period. The growth opportunities in the Asia-Pacific region can be attributed to the presence of a large patient population for target diseases (coupled with rapidly growing geriatric population, especially in Japan and China), rising awareness among healthcare professionals related to needlestick injuries, ongoing government initiatives to modernize & expand healthcare infrastructure, and continuous reduction in product prices.

Global Key Leaders:

Septodont (U.S.), 3M Company (U.S.), Dentsply International, Inc. (U.S.), Integra LifeSciences Corporation (U.S.), Vista Dental Products (U.S.), Power Dental USA, Inc. (U.S.), 4tek S.r.l (Italy), A. Titan Instrument Inc. (U.S.), and Delmaks Surgico (Pakistan) were some of the key players operating in the dental syringes market.

Featured post

Antares Vision (Italy), OPTEL Vision (Canada) are Prominent Players in the Track and Trace Solutions Market

The Track and Trace Solutions Market by Product (Plant Manager, Checkweigher, Barcode Scanner, Monitoring), Technology (2D Barcode, RFID), Application (Serialization, Aggregation, Reporting), End User (Pharma, Food, Medical Devices) – Global Forecast to 2026″, is projected to reach USD 7.3 billion by 2026 from USD 4.1 billion in 2021, at a CAGR of 12.1% during the forecast period.

COVID-19 Impact on the Track and Trace Solutions Market;

COVID-19 is an infectious disease caused by the most recently discovered novel coronavirus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks. The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11, 2020. Since the beginning of 2020, most countries worldwide shut down their borders and limited transportation in a bid to contain the coronavirus (COVID-19) outbreak, thus, creating impediments for international trade and transportation. This disrupted the supply chains for the track and trace market, temporarily leading to a fall in demand due to uncertainty in the global economy and capital markets.

We estimate that the major share of the medical device industry, which includes imaging devices, dental care devices, and surgical products, contributes 60–75% of the overall medical devices market. This will have a stagnant or deep fall in the growth rate in 2020 and in a couple of quarters from 2021. A new USD-5–7 billion market opportunity (by 2021) is opening up in the medical devices industry, including critical care medical devices.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158898570

Track and Trace Solutions Market
Track and Trace Solutions Market

“The 2D Barcode segment accounted for the largest market share in 2020.”

Based on technology, the track and trace solutions market is segmented into linear barcodes, 2D barcodes, and radiofrequency identification (RFID). The 2D barcodes segment accounted for the largest share of 76.2% of the technology market in 2020. This segment is projected to grow at a CAGR of 12.4% to reach USD 5,641.3 million by 2026. The large share of the 2D barcodes technology segment can be attributed to the increasing use of 2D barcodes in the packaging industry. They have higher data storage capacities than linear barcodes and contain larger amounts of data with fewer variations in image size.

The RFID segment is expected to register the highest CAGR of 13.7% during the forecast period due to the growing demand for these systems in automated pharmaceutical distribution and medical devices due to low labor costs and improved visibility & planning.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158898570

Geographical View in-detailed:

The track and trace solutions market studied in this report is divided into five major regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 42.9% of the global track and trace market, followed by Europe (33.5%). The presence of developed healthcare systems in the US & Canada; the presence of many pharmaceutical & biotechnology companies and medical device manufacturers; stringent regulations regarding serialization; and the growing medical devices market are major factors driving market growth in North America.

Some of the prominent players in the track and trace solutions market are OPTEL GROUP (Canada), Mettler-Toledo International Inc. (US), Systech International Inc. (US), TraceLink Inc. (US), Antares Vision (Italy), SAP (US), Xyntek Inc. (US), SEA Vision Srl (Italy), Syntegon (Germany), Körber Medipak Systems AG (Switzerland), Siemens AG (Germany), Uhlmann Group (Germany), JEKSON VISION (India), Videojet Technologies, Inc. (US), Zebra Technologies Corporation (US), Axway Inc. (US), ACG Worldwide (India), Laetus GmbH (Germany), and WIPOTEC-OCS (Germany).

Featured post

Global Animal Genetics Market Size, and Growth Projection

According to the new market research report “Animal Genetics Market by Products & Services (Live Animals (Poultry, Porcine, Bovine, Canine) Genetic Material (Semen (Bovine, Porcine), Embryo (Bovine, Equine)) Genetic Testing (DNA Testing, DNA Typing, Genetic Traits Testing)) – Global Forecast to 2026″, published by MarketsandMarkets™, the Animal Genetic Products Market is projected to reach USD 7.7 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 7.1% during the forecast period.

Browse in-depth TOC on “Animal Genetics Market”
269 – Tables
36 – Figures
296 – Pages

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12462093

Animal Genetics Market
Animal Genetics Market

The growth of Animal Genetic Products Market is majorly attributed to the increasing consumption of animal-derived protein, growing global population & rapid urbanization, growing focus on identifying superior breeds, increased adoption of genetic services to prevent genetic diseases & business loss, and increased adoption of advanced genetic technologies. On the other hand, the shortage of skilled professionals in veterinary research is a key factor restraining Live animals market growth.

The live animals segment accounted for the largest market share during the forecast period.

Based on products and services, the animal genetics market has been segmented into live animals, genetics materials, and animal genetic testing services. The factors attributing to the large revenue of the live animals segment include high demand for live animals for breeding purposes. The introduction of disease-resistant animals has further boosted the demand for live animals, as they are economically viable for owners and increase their profitability.

Poultry accounted for the largest animal genetics market share in the live animals segment during the forecast period.

In the live animals segment, poultry accounted for the largest market share during the forecast period. This can be attributed to the strong demand for poultry and eggs in developed countries. Additionally, due to the growing population and rapid urbanization in developed countries, the demand coming from these regions is also increasing significantly.

In the segment of the genetic material, semen accounted for the largest market share during the forecast period.

Under the segment of the genetic material, semen held the largest share, most of which came from bovine semen during the forecast period. Growth in this market is mainly driven by the increasing need for raising highly productive animals to meet the growing demand for meat and other animal-derived products.

Request Sample Pageshttps://www.marketsandmarkets.com/requestsampleNew.asp?id=12462093

Europe dominates the Animal Genetics market during the forecast period.

Geographically; The Europe accounted for the largest share of the Live animals market in 2020. Better accessibility to technologies and well-established distribution channels, the growing demand for livestock food products, high intake of animal-derived proteins, and increasing animal welfare activities are the major factor contributing to this.

The major players in the global animal genetics market include Neogen Corporation (US), Genus (UK), URUS (US), EW Group (Germany), Groupe Grimaud (France), CRV Holding (Netherlands), Topigs Norsvin (Netherlands), Zoetis (US), Envigo (US), Hendix Genetics (Netherlands), Animal Genetics (US), VetGen (US), DanBred (Denmark), Tropical Bovine Genetics (India), Trans Ova Genetics (US), Inguran LLC dba ST Genetics (US), Semex Alliance (Canada), Genetic Veterinary Sciences (US), Cobb-Vantress (US), Milk Source (US), and Eurogene AI Services (Ireland).

Speak to Analysthttps://www.marketsandmarkets.com/speaktoanalystNew.asp?id=12462093

Microfluidic Components Market worth $6.1 billion – Regenerative Medicine an Alternative to Organ Transplantation

In this report, the global market size for microfluidic components was arrived at after the assessment of major product segments and their share in the overall Microfluidic Components Market. For this purpose, the share of major product segments was determined through various insights gathered during the primary and secondary research. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

The major factors driving the growth of this market are the rising demand for point-of-care testing, technological advancements, increasing focus on data precision and accuracy, fast return on investments, growing demand for miniature portable devices, and growing demand for consumer electronics and wearable devices.

According to the new market research – The report “Microfluidic Components Market by Product (Valve, Solenoid Valve, Check Valve, Nozzle, Tubing, Micropump, Microneedle, Shuttle Valve), Industry (Automotive, Aerospace & Defense, Healthcare, Consumer Electronics, Oil & Gas) – Global Forecast to 2024”, is expected to reach USD 6.1 billion by 2024 from an estimated USD 3.3 billion in 2019, at a CAGR of 12.7%.

Request Research Sample Pageshttps://www.marketsandmarkets.com/requestsampleNew.asp?id=223516809

Microfluidic Components Market
Microfluidic Components Market

Based on valve type;

The microfluidic components market is segmented into solenoid valves, flow control valves, check valves, shuttle valves, pressure relief valves, proportional valves, and other valves. Solenoid valves are expected to grow at the highest CAGR during the forecast period due to factors like increased application scope in the automotive industry, the shift towards renewable sources for power generation, growing investments in various industries, and increasing government regulations on end-use industries across developing economies.

The APAC market is projected to register the highest growth during the forecast period. Factors such as increasing industrialization, investments in water infrastructure, growth in various industries (such as chemicals, power & energy, and aerospace), increasing number of infrastructural development projects (especially in China and India), rising standard of living, and growing urbanization are some of the key factors driving the growth of the microfluidic components market in the APAC region.

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=223516809

The prominent players in the microfluidic components market are Parker Hannifin Corporation (US), IDEX Corporation (US), Fluigent SA (France), Staiger GmbH & Co. KG (Germany), SMC Corporation (Japan), Camozzi Automation Spa Società Unipersonale (Italy), Aignep s.p.a. (Italy), FIM Valvole Srl (Italy), Humphrey Products Corporation (US), The Lee Company (US), Dolomite Microfluidics (UK), Cellix Ltd. (Ireland), Elveflow (France), and Christian Bürkert GmbH & Co. KG (Germany).

Parker Hannifin (US) is a leading manufacturer of motion & control technologies and systems that provides precision-engineered solutions for the commercial, mobile, industrial, and aerospace markets. The company has engineering expertise in a broad range of core technologies, which helps it to solve various engineering challenges. The company has a strong geographical presence and sells its products in North America and Europe. Furthermore, to expand its territorial reach, the company sells its products in Asia and the Middle East through its strong distribution network. Its diverse range of products makes Parker the leading supplier of microfluidic components that meet and exceed market demands.

Global Orthopedic Braces & Supports Market 2020 Industry Trends, Growth Analysis, and Forecast

According to the new market research report “Orthopedic Braces and Supports Market by Product (Knee, Ankle, Hip, Spine, Shoulder, Neck, Elbow, Hand, Wrist), Category (Soft, Hard, Hinged), Application (Ligament (ACL, LCL), Preventive, OA), Distribution (Hospital) & Region – Global Forecast to 2025″, published by MarketsandMarkets™, the Orthopedic Braces Market size is estimated to be USD 3.1 billion in 2020 and projected to reach USD 4.1 billion by 2025, at a CAGR of 5.8 %.

Browse in-depth TOC on “Orthopedic Braces and Supports Market”
280 – Tables
30 – Figures
374 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=24806829

orthopedic-braces-and-supports-market

The Increasing prevalence of orthopedic diseases & disorders, continuous product commercialization, greater product affordability & market availability, rising number of sports and accident-related injuries, and growing public awareness related to preventive care are the key factors driving the growth of the orthopedic braces and supports industry.

The Orthopedic Braces And Supports Market includes major Tier I and II suppliers like DJO Finance LLC (US), Össur Hf (Iceland), Breg, Inc. (US), Bauerfeind AG (Germany), and DeRoyal Industries, Inc. (US). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Demand for orthopedic braces and supports from key end-users has significantly declined amidst the global COVID-19 pandemic. Industry experts believe that COVID-19 will have short-term negative growth for the orthopedics and supports market in 2020, but will experience normal growth as the market gradually steadies by the end of 2020.

Demand for knee braces and supports among medical professionals and athletes is expected to result in the segment occupying the majority of the market share

The knee braces and supports market is estimated to have the largest market share by value. Growth of this segment can be attributed to the growing demand for knee braces & supports among medical professionals and athletes and favorable reimbursement scenario for knee braces in developed countries. Moreover, growing geriatric & obese population (which are at a higher risk of developing osteoarthritis and other knee-related conditions), and the increasing number of sports injuries is expected to drive the market growth.

Lower spine braces estimated to be the largest and fastest-growing market

Lower spine braces are estimated to be the largest and fastest-growing segment in the Orthopedic Braces And Supports Market. The growth of this segment can be attributed to the rising incidence of lower spine disorders and the growing number of hip & disc replacement surgeries (which utilize lower spine braces and supports for post-operative rehabilitation).

North America is estimated to be the largest market due to the continuous development and commercialization of novel orthopedic braces & support products, favorable reimbursements & insurance coverage for major orthopedic bracing procedures, supportive government regulations for product commercialization, and significant sports participation.

Request Research Sample Pageshttps://www.marketsandmarkets.com/requestsampleNew.asp?id=24806829

Asia Pacific likely to emerge as the largest Orthopedic Braces Market.

Asia Pacific is estimated to be the fastest-growing market for orthopedic braces and supports during the forecast period. The Asia Pacific market is driven principally by the rising geriatric and obese population (coupled with the significant prevalence of orthopedic & diabetes-related diseases in this population segment), increasing GDP and healthcare expenditure in APAC countries, and growing public awareness. Furthermore, increasingly localized product manufacturing, favorable government regulations, and the focus of global product manufacturers on expanding their presence in APAC countries are aiding the market growth.

DJO Finance LLC (US), Össur Hf (Iceland), Breg, Inc. (US), Bauerfeind AG (Germany), and DeRoyal Industries, Inc. (US) are the key players in the global Orthopedic Braces And Supports Market.

Worldwide Leukapheresis Market Size, Opportunities for Revenue Growth, and Future Forecast

According to the new market research report “Leukapheresis Market by Product (Devices, Filters, Columns, Disposables), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) – Global Forecast to 2026″, published by MarketsandMarkets™, the global Leukapheresis Market is projected to reach USD 91 million by 2026 from USD 61 million in 2021, at a CAGR of 8.4% during the forecast period.

The leukopaks market is expected to reach USD 662 million by 2026, at a CAGR of 41.9%.

Browse in-depth TOC on “Leukapheresis Market”
185 – Tables
66 – Figures
247 – Pages

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=20283148
leukapheresis-market8
The Leukopaks are enriched leukapheresis products that contain higher concentrations of leukocytes. The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets. However, the high cost of therapeutic leukapheresis andc cellular therapies, stringent donor recruitment criteria, and long procedural time for leukapheresis are restraining the growth of this market to a certain extent.

The leukapheresis disposables segment is expected to account for the largest share of the leukapheresis products market

Based on type, the leukapheresis market is segmented into leukapheresis disposables and leukaphersis devices. The large share of the leukapheresis disposables segment can be attributed to the recurrent use of disposables during leukapheresis procedures, increasing adoption of leukapheresis products for the collection of leukopaks and isolated PBMCs from leukopaks for research applications, and the increasing adoption of therapeutic leukapheresis procedures.

The research applications segment expected to grow at highest CAGR in the leukapheresis products market in the forecast period

Based on application, the leukapheresis market is segmented into research and therapeutic applications. The research applications segment is expected to grow at the highest CAGR in the leukapheresis products market during the forecast period. The large share of this segment is attributed to the increasing adoption of leukapheresis products for the development of cell-based immunotherapies and leukapheresis-derived primary cells in drug development.

The blood component providers & blood centers segment holds the highest market share in the leukapheresis products market

Based on end user, the leukapheresis market is segmented into blood component providers & blood centers, academic and research institutes, pharmaceutical & biotechnology companies, hospitals & transfusion centers. Blood component providers & blood centers hold the largest share in this market. The large share of this segment can be attributed to growing demand for leukopaks for the development of CAR T-cell therapies, and the increasing demand for blood components in clinical conditions such as cancer.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20283148

The leukopaks market, the diseased leukopaks segment is projected to grow at the highest rate forecast period

Based on type, the market is segmented into mobilized leukopaks, non-mobilized leukopaks, diseased leukopaks, and isolated PBMCs. In this segment, the diseased leukopaks segment is projected to register the highest growth during the forecast period. The increasing demand for diseased-state leukopaks for cell interaction studies, drug toxicity studies, preclinical development of cell-based therapeutics, immunotherapy, immune-oncology studies, and regenerative medicine is driving the growth of this segment.

The acute lymphocytic leukemia segment holds the largest share in the leukopaks market

Based on indication, the acute lymphocytic leukemia segment accounts for the largest share of the market, by indication. The large share of this segment can be attributed to the increasing focus of pharmaceutical companies on the development of leukopak-based cell therapies for the treatment of acute lymphocytic leukemia (ALL) and a high number of CAR T-cell therapy clinical trials for ALL.

The pharmaceutical & biotechnology companies segment is expected to grow at the highest CAGR in the leukopaks market in the forecast period

Based on end user, the leukopaks market is segmented into pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes. Pharmaceutical and biotechnology companies are projected to grow at the highest CAGR in this market in the forecast period. Thi highest growth rate can be attributed to increasing collaboration of pharmaceutical companies with academic institutes, research centers, and hospitals for new drug development.

Speak to Analysthttps://www.marketsandmarkets.com/speaktoanalystNew.asp?id=20283148

North America to dominate the Leukapheresis products and leukopaks market during the forecast period

The leukapheresis market is segmented into North America, Europe, Asia Pacific, and Rest of the World. The large share of this region can be attributed to the increasing adoption of leukapheresis products for the development of leukoreduced plasma and leukoreduced RBCs, growing adoption of leukopaks as a source of primary cells for research applications, increasing number of clinical trials for the development of CAR T-cell therapy using leukopaks.

Prominent players in the Leukapheresis products and leukopaks market include Asahi Kasei Medical Co. Ltd. (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Charles River Laboratories (US), AllCells, LLC (US), and StemExpress, LLC. (US).

In Vivo Toxicology Market future growth probabilities and Comprehensive Analysis & Key Players are Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp)

According to the new market research report In Vivo Toxicology Market by Product (Animal Models, Reagents & Kits), Test Type (Chronic, Sub-acute), Toxicity Endpoints (Systemic, Immunotoxicity), Testing Facility (Outsourced, In-house), End User (Academic & Research Institute, CROs) – Forecast to 2025″, published by MarketsandMarkets™, the global Toxicity Testing Market size is projected to reach USD 6.6 billion by 2025, at a CAGR of 5.5% between 2020 and 2025.

Browse in-depth TOC on“In Vivo Toxicology Market”

305 – Tables
40 – Figures
276 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105308811

in-vivo-toxicology-testing-market8

The Market growth is driven largely by the increasing pharmaceutical R&D activities, innovations in animal models, the development of exclusive in vivo toxicology tests, and the increasing demand for personalized medicine.

Consumables accounted for the largest share in the in vivo toxicology market in 2019.

Based on the product, the market is categorized into instruments and consumables. The consumables segment is further categorized into animal models and reagents & kits. Animal models is sub segmented into mice, rat and other animals. The consumables segment accounted for the largest share of the market in 2019. The widespread use of reagents & kits in research activities, increase in funds for research projects, and their extensive application in the in vivo toxicology studies are fueling the growth of this segment.

Chronic test type accounted for the largest share in the toxicity testing market in 2019

Based on test type, segmented into acute, sub-acute, sub-chronic, and chronic test type. The chronic test type segment is expected to dominate the market during the forecast period. In 2019, the chronic test type segment held the largest share of the market, followed by sub-chronic test type. Increasing research on drugs used for longer-duration therapy such as anti-cancer, anti-convulsive, anti-arthritis, and anti-hypertensives drives the growth of the chronic test type market.

Outsourced testing facilities accounted for the largest share in the in vivo toxicology market in 2019

Based on the testing facility, the global toxicity testing market is segmented into outsourced testing facilities and in-house testing facilities. The outsourced testing facilities segment is expected to dominate the market, by testing facility, over the forecast period. In 2019, the outsourced testing facilities segment held the largest share of the global market. The large share of this segment is attributed to the increasing R&D investments and cost-saving strategies of pharmaceutical, biopharmaceutical, and medical devices companies, resulting in increased outsourcing of services to CROs.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=105308811

Academic and research institutes accounted for the largest share the market in 2019

Based on the end user, the global market has been broadly segmented into academic & research institutes, pharmaceutical & biotechnology companies, contract research organizations, and other end users (cosmetic companies and food laboratories). The academic and research institutes segment accounted for the largest share of the in vivo toxicology market in 2019. The increasing number of research activities in the field of in vivo toxicology and funding to the academic and research institutes to conduct in vivo toxicology research are the factors responsible for the largest share of the segment.

North America accounted for the largest share of the toxicity testing market in 2019.

Based on the region, the global in vivo toxicology market is segmented into North AmericaEurope, the Asia PacificLatin America and Middle East & Africa. In 2019, North America accounted for the largest share of the market. The large share of the North America region can be attributed to the presence of major players operating in the market in the US, growing biomedical research in the US, and rising preclinical activities by CROs and pharmaceutical companies in the region.

The major players operating in Toxicity Testing Market are by Charles River Laboratories (US), The Jackson Laboratory (US), Envigo (US), Taconic Biosciences, Inc. (US), and JANVIER LABS (France), Thermo Fisher Scientific (US), Danaher Corporation (US), Waters Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), Bruker Corporation (US), PerkinElmer (US). Other prominent players include Merck KGaA (Germany), GE Healthcare (US), and Bio-Rad Laboratories (US), genOway (France), Cyagen Biosciences (US), GVK BIO (India), PolyGene (Switzerland), Crown Biosciences (US), TransCure bioServices (France), Ozgene Pty Ltd. (Australia), Harbour BioMed (US) among others.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=105308811

Abbott Laboratories (US) and Thermo Fisher Scientific (US) are Leading Players in the Therapeutic Drug Monitoring Market

According to the new market research report Therapeutic Drug Monitoring Market by Product (Equipment (Immunoassay Analyzers), Consumables), Technology (Immunoassays, Chromatography-MS), Class of Drugs (Antibiotic Drugs, Bronchodilator Drugs), End User – Global Forecast to 2025″, published by MarketsandMarkets™, the TDM Market is projected to reach USD 2.0 billion by 2025 from USD 1.4 billion in 2020, at a CAGR of 6.9% from 2020 to 2025

Browse in-depth TOC on “Therapeutic Drug Monitoring Market”

288 – Tables
35 – Figures
241 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155350443

therapeutic-drug-monitoring-market11

The TDM Market growth is largely driven by factors such as the rising number of organ transplant procedures, the use of TDM across various therapeutic fields, the increasing preference for precision medicine, a growing focus on R&D related to TDM, and technological advancements in immunoassay instruments. Increasing adoption in the treatment of autoimmune diseases is expected to provide a wide range of growth opportunities for players in the market.

Consumables is expected to hold the largest share of the therapeutic drug monitoring market in 2020

On the basis of product, the market is segmented into equipment and consumables. In 2019, consumables segment accounted for the largest market share, primarily due to the repeat purchases of kits and reagents and the increasing number of immunoassay tests being performed across the globe.

Immunoassays is expected to hold the largest share of the TDM Market in 2020

Based on technology, segmented into immunoassays and chromatography-MS. In 2019, immunoassays segment accounted for the largest market share, due to the increasing incidence of chronic and infectious diseases and technological innovation.

Antiepileptic drugs is expected to hold the largest share of the therapeutic drug monitoring market in 2020

On the basis of class of drug, the market is segmented into antiepileptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive agents, and other drugs. During 2019, antiepileptic drugs held the largest share among the class of drug due to the high complexity and heterogeneity of epilepsy, lack of biological markers or specific clinical signs aside from the frequency of seizures to assess treatment efficacy or toxicity, and the highly complex pharmacokinetics of these drugs.

Hospital laboratories segment commanded the largest share of the TDM Market in 2019

By end user, the market is segmented into hospital laboratories, commercial & private laboratories, and other end users. Hospital laboratories accounted for the largest share of the market in 2019. The large share of this segment can be attributed to factors such as the availability of advanced healthcare facilities in hospitals and the rising incidences of chronic diseases.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=155350443

North America commanded the largest share of the therapeutic drug monitoring market in 2019.

On the basis of region, the market is segmented into North AmericaEuropeAsia PacificLatin America, and the Middle East & Africa. In 2019, North America commanded the largest share of the market. Increasing per capita healthcare expenditure and the presence of technologically advanced healthcare infrastructure in the region, coupled with initiatives taken by different government associations, are anticipated to boost the market growth in the region.

The major players operating in this therapeutic drug monitoring market are Abbott Laboratories (U.S.), F. Hoffmann-La Roche (Switzerland), Siemens Healthineers (Germany), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Bio-Rad Laboratories (U.S.), bioMérieux (France), BÜHLMANN Laboratories (Switzerland), SEKISUI MEDICAL (Japan), Randox Laboratories (Ireland), DiaSystem Scandinavia AB (Sweden), Cambridge Life Sciences Limited (United Kingdom), ARK Diagnostics, Inc. (U.S.), Chromsystems Instruments & Chemicals GmbH (Germany), Grifols (Spain), Exagen Inc. (U.S.), Theradiag (France), R-Biopharm AG (Germany), apDia Group (Belgium), BioTeZ Berlin-Buch GmbH (Belgium), Eagle Biosciences Inc. (U.S.), JASEM Laboratory Systems and Solutions A.S (Turkey), Aalto Scientific (U.S.), Immundiagnostik AG (Germany), and UTAK (U.S.).

Foot and Ankle Devices Market worth $5.3 billion by 2025 – Exclusive Report by MarketsandMarkets™

According to the new market research report “Foot and Ankle Devices Market by Product (Implants, Plates, Screw, Wires, Internal Fixators, Braces, Prosthesis (SACH, Single/Multi-Axial)), Application (Rheumatoid Arthritis, Osteoporosis, Hammertoe), Enduser (Hospital, ASCs) – Global Forecasts to 2025″, published by MarketsandMarkets™, the global market is projected to reach USD 5.3 billion by 2025 from USD 3.9 billion in 2020, at a CAGR of 6.4% during the forecast period.

Browse in-depth TOC on “Foot and Ankle Devices Market”

280 – Tables
38 – Figures
310 – Pages

Download PDF Brochure
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=845


The growth of Foot and Ankle Implants Market is mainly driven by the growing number of hospitals across major markets, increasing awareness about complication related to foot and ankle related to osteoarthritis and diabetes coupled with the increasing adoption of bracing and support devices. Moreover, rising R&D investments by the key players operating in the market to develop advanced foot and ankle devices coupled with growing funding & grants for commercialization and development of foot and ankle devices are other important factors to drive the market growth in the near future.

The Internal fixation devices sub segment of fixation devices products to hold major market share by 2025

Based on the product, the foot and ankle devices market is segmented into orthopedic implants and devices, prostheses, and bracing and support devices. The orthopedic implants and devices products segment is further divided into Fixation devices, joint implants, and soft tissue orthopedic devices. Among the fixation devices products, the internal fixation devices segment held a major share of the market in 2019. Internal fixation devices include screws, plates, wires & pins, and fusion nails. These devices are used in foot and ankle injuries resulting from conditions such as trauma, neurological disorders, bunions, arthritis, and osteoporosis. Internal fixation devices are more effective and reduce the incidences of malunion or nonunion of the injured bones. These implants are made of stainless steel, titanium, cobalt, or chrome. The wide applications of Internal fixation devices devices in foot and ankle injuries and disorders management are a major factor contributing to the growth of this market segment.

The trauma and hair line fracture segment is expected to account for the largest share of the foot and ankle devices market in 2019

Based on application, segmented into the rheumatoid arthritis & osteoarthritis, trauma and hairline fractures, diabetic foot diseases, neurological disorders, ligament injuries, hammertoe, and other applications. Among these, the trauma and hairline fractures sub-segment dominated the market in 2019. The major share of the segment is attributed to the rising sport injuries in developing as well as developed countries. As of 2018, 265 million people participated in soccer across the globe, according to Fédération Internationale de Football Association (FIFA). New products have been introduced in the market that allow for easier reconstruction for sport injuries.

The hospital segment is expected to register the highest growth rate during the forecast period

Based on end user, the foot and ankle devices market has been segmented into the hospitals, ambulatory surgery centers, orthopedic clinics and rehabilitation centers. Significant market growth and large share of hospital segment can primarily be attributed to the presence of advanced surgical wards and emergency wards in hospitals and the increasing number of surgical procedures.

Request Sample Pages
https://www.marketsandmarkets.com/requestsampleNew.asp?id=845

North America is expected to dominate the global patient monitoring market in 2019

North America, comprising the US and Canada, accounted for the largest share of the foot and ankle devices market in 2019. Increasing number of clinical trials validating foot and ankle devices and a growing number of approvals forfoot and ankle devices are the major factors driving market growth in North America. Customers in North America are moving towards ambulator surgical centers, which is increasing decal centers, which is increasing demand for foot and ankle devices. This trend will have a positive impact on the foot devices market.

DePuy Synthes Companies (US), Stryker Corporation (US), Zimmer Biomet Holdings, Inc (US), Smith & Nephew plc (UK), Arthrex Inc (US), Integra LifeSciences Holdings Corporation (US), DJO Finance, LLC (US), CONMED Corporation (US), Össur HF (Iceland), Orthofix Medical Inc. (US), Medartis AG (Switzerland), Acumed LLC (US), Extremity Medical (US), aap Implantate AG (Germany), Ottobock SE & Co. KGaA (Germany), Ortho Solutions UK Ltd. (UK), Vilex in Tennessee, Inc. (US), Advanced Orthopaedic Solutions (US), Fillauer LLC (US), and Groupe FH Ortho (France),among others are some of the major players operating in the global foot and ankle devices market.

Speak to Analyst
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=845

Anatomic Pathology Track and Trace Solutions Market – Growth by Top Key Players, Application and Forecast Analysis

According to the new market research report “Anatomic Pathology Track and Trace Solutions Market by Product (Software, Hardware (Printer & Labeling Systems), Consumables), Technology (Barcode, RFID), Application (Tissue Cassette, Slide Tracking), End User (Hospital Labs) – Global Forecast″, published by MarketsandMarkets™, is projected to reach USD 695.7 million by 2023 from USD 424.2 million in 2018, at a CAGR of 10.4%.

Browse in-depth TOC on “Anatomic Pathology Track and Trace Solutions Market”
112 – Tables
34 – Figures
165 – Pages

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124099392

anatomic-pathology-track-trace-solution-market2

Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The track and trace solutions are used to keep track of a specimen’s journey throughout the testing process. Barcode and RFID technology is used for labeling and identification of assets in anatomic pathology laboratories. The implementation of track & trace solutions and technologies are increasingly adopted by anatomic pathologists to reduce errors related to the manual labeling process.

The software segment accounted for the largest share of the anatomic pathology track and trace solutions market

On the basis of product, segmented into software, hardware, and consumables. In 2017, the software segment accounted for the largest share of the anatomic pathology track and trace solutions market. The growth of this segment is mainly driven by the growing need to automate the sample labeling process to reduce manual errors, increasing focus on improving the efficiency of anatomic laboratories, growing adoption of cloud-based LIMS, and rising workload in anatomic pathological laboratories.

The slides tracking segment accounted for the largest share

Based on application, the anatomic pathology track and trace solutions market is segmented into slides tracking, tissue cassettes and blocks tracking, and specimen tracking. In 2017, the slides tracking segment accounted for the largest share of themarket. The large share of this segment is mainly attributed to its ability to help eliminate labeling errors and maintain optimal patient safety.

The barcode segment accounted for the largest share

On the basis of technology, the anatomic pathology track and trace solutions market is segmented into barcode and radiofrequency identification (RFID). The barcode segment accounted for the largest market share in 2017. The large share of this segment is attributed to the increased adoption of barcode systems in anatomic pathology laboratories for accurate specimen identification. However, the RFID segment is projected to register the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing adoption of this technology by large chain pathological laboratories due to the advantages offered by RFID systems such as increased data storage and higher reader throughput, as compared to barcode systems.

The hospital laboratories segment accounted for the largest share

On the basis of end user, the anatomic pathology track and trace solutions market is segmented into hospital laboratories, independent and reference laboratories, and other end users (contract research organizations, government-funded medical laboratories, and research institutes). In 2017, the hospital laboratories were the largest end users of anatomic pathology track and trace solutions .The growth of this segment can be attributed to the increasing number of cancer diagnostic tests performed in hospital laboratories, growing number of in-house clinical diagnostic procedures in hospitals, increasing number of hospitals across the globe, and the increasing availability of reimbursement coverage for hospital-based diagnostic tests across developed countries.

Request Research Sample Pageshttps://www.marketsandmarkets.com/requestsampleNew.asp?id=124099392

Asia Pacific is expected to account for the highest CAGR for players operating in the anatomic pathology track and trace solutions market

Based upon region, broadly segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2017, North America accounted for the largest share of the anatomic pathology market, followed by Europe, Asia Pacific, Latin America, and the Middle East & Africa.The Asia Pacific region is projected to register the highest growth rate in the track and trace solutions market during the forecast period. The presence of emerging economies such as China, India, and Japan; improving standard of living; growing demand for quality medical care; increasing healthcare spending; government initiatives; rising awareness about the use of anatomic pathology tests among physicians; and growth in the demand for cancer diagnostics are driving the growth of the market in Asia Pacific.

The key players operating in the global anatomic pathology track and trace solutions market are Thermo Fisher Scientific (US), Leica Biosystems (Germany), General Data Healthcare (US), Ventana Medical Systems (US), Agilent Technologies (US), Sunquest Information Systems (US), Zebra Technologies Corporation (US), Primera Technology (US), Cerebrum Corporation (US), AP Easy Software Solutions (US), and LigoLab (US).

Major Insights on Single Use Assemblies Market – Global Growth Opportunities

According to the new market research report “Single-use Assemblies Market by Product (Bag Assembly, Filtration Assembly, Bottle Assembly, Mixing Assembly), Application (Filtration, Storage), Solution (Standard, Customized), End User (Pharmaceutical, Biopharma, CMOs, CROs) – Global Forecast to 2026″, published by MarketsandMarkets™, the global market is projected to reach USD 6.3 billion by 2026 from USD 2.2 billion in 2021, at a CAGR of 23.3% during the forecast period.

Browse in-depth TOC on “Single-use Assemblies Market”
276 – Tables
32 – Figures
247 – Pages

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46226549

single-use-assemblies-market12

The growth of the market can primarily be attributed to the major advantages of single-use technologies as compared to traditional stainless-steel assemblies, such as rapid implementation and the low risk of cross-contamination. The increasing biopharmaceutical R&D expenditure and growing biologics market are also driving the market growth.

The biopharmaceutical & pharmaceutical companies segment accounted for the largest share of the end user segment in the single-use assemblies market in 2020.

On the basis of end users, the market is segmented into biopharmaceutical & pharmaceutical companies, contract research & manufacturing organizations (CROs & CMOs), and academic & research institutes. In 2020, the biopharmaceutical & pharmaceutical companies segment accounted for the largest share of the single use assemblies market. The demand for biopharmaceuticals among the geriatric population is increasing as the elderly are more prone to diseases/disorders, which are treated using biologics. This has resulted in the increased focus of biopharmaceutical companies on developing affordable biologics at lower costs. As single-use assemblies have wide applications in each stage of the production cycle, their adoption is increasing with the growth in the production of biologics and biosimilars.

The standard solutions segment accounted for the largest share of the solutions segment in the single-use assemblies market in 2020.

Based on solution, the market is segmented into standard solutions and customized solutions. In 2020, the standard solutions segment accounted for the largest share of the market. The adoption of standard solutions is high in the pharmaceutical & biopharmaceutical industries due to the advantages these solutions offer, such as manufacturing process efficiency with reduced capital costs, improved flexibility with the use of pre-qualified components for building assemblies, reduced implementation time, and more flexibility with production planning.

Request Sample Pageshttps://www.marketsandmarkets.com/requestsampleNew.asp?id=46226549

Geographically; In 2020, the Asia Pacific region accounted for the fasted growing region of the Single use Assemblies Market. This can be attributed to the growing biopharmaceutical market and biopharmaceutical manufacturing capabilities in Asian countries, rising life science research activities, increasing investments by pharmaceutical & biotechnology companies, and the growth of the contract R&D sector.

Prominent players operating in the single-use assemblies market are Thermo Fisher Scientific, Inc. (US), Sartorius Stedim Biotech (France), Danaher Corporation (US), Merck KGaA (Germany), Avantor, Inc. (US), and Saint-Gobain (France).

Prefilled Syringes Market | Segmentation | Opportunities | Key Players

According to the new market research report Prefilled Syringes Market by Type [Conventional (Disposable, Reusable), Safety], Material (Glass, Plastic), Design (Single-Chamber, Dual-Chamber, Customized), Application (Diabetes, Cancer, Arthritis, Anaphylaxis, Ophthalmology) – Global Forecast to 2025″, published by MarketsandMarkets™, is estimated to be USD 5.6 billion in 2020 and projected to reach USD 8.6 billion by 2025, at a CAGR of 9.0%.

The Rising target disease population, rapid growth in generic products, rising adoption of self-medication and digitalization, affordable cost with increased efficiency, and technological advancements are the major factors driving the growth of the market. Furthermore, growing initiatives undertaken by leading market players to establish production facilities in both mature and developing markets are the key factors driving the growth of the prefilled syringes industry.

Browse and in-depth TOC on “Prefilled Syringes Market”

104 – Tables

30 – Figures

149 – Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=16618331

prefilled-syringes-market5

The prefilled syringes market includes major Tier I and II suppliers like Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), and West Pharmaceutical Services, Inc. (US), and Nipro Corporation (Japan). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Routine care for chronic diseases is an ongoing challenge amidst the global COVID-19 pandemic due to the change in routine care to virtual communication. Diabetes, chronic obstructive pulmonary disease, and hypertension were the most impacted conditions due to a reduction in access to care. Furthermore, currently, most global healthcare resources are focused on coronavirus disease (COVID-19), and this resource reallocation is expected to disrupt the continuum of care for patients with chronic diseases.

Increasing adoption of self-administered injectable drugs is expected to result in the segment occupying the majority of the market share

The conventional prefilled syringes market is estimated to have the largest market share by value. Growth of this segment can be attributed to the the advantages offered, such as safe administration, ease of use for both healthcare professionals and end users, reduced risk of contamination of the product, less waste of costly API, ease of manufacturing, improved dosing accuracy, and enhanced product differentiation when compared to vials is expected to drive the market growth.

Plastic Prefilled Syringes estimated to be the fastest-growing market

Plastic prefilled syringes are estimated to be the fastest-growing segment in the prefilled syringes market. The growth of this segment can be attributed to the rising development of newer polymers (which possess various physical and chemical properties such as high heat & break resistance, tolerance of freeze-drying & liquid nitrogen exposure, high transparency, and solvent resistance.

Europe is estimated to be the largest market due to the rising prevalence of chronic diseases, growth of the biologics and biosimilars market, technological advancements, geographical expansion by key manufacturers, aging population, and high adoption of self-injection devices are driving the demand for self-injectable prefilled syringes.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=16618331

Asia Pacific likely to emerge as the largest prefilled syringes market, globally

Asia Pacific is estimated to be the fastest-growing market for prefilled syringes during the forecast period. The Asia Pacific market is driven principally by the increasing demand for self-administered treatments, high penetration of self-injection devices, growing aging population, increasing prevalence of diabetes, and huge patient population.

Becton, Dickinson and Company (US), Gerresheimer (Germany), SCHOTT AG (Germany), and West Pharmaceutical Services, Inc. (US) are the key players in the global prefilled syringes market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=16618331

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

Browse Related Reports:

Dental Syringes Market by Product (Non-disposable Syringes, Disposable Syringes and Safety Syringes), Type (Aspirating & Non-aspirating), Material (Plastic and Metallic), Region (North America, Europe , Asia-Pacific, and RoW) – Forecast to 2021

https://www.marketsandmarkets.com/Market-Reports/dental-syringe-market-42523876.html

Fill Finish Manufacturing Market by Product (Consumables (Prefilled Syringes (Glass, Plastic}, Vial), Instruments (Systems {Stand alone, Integrated), Machine Type {Automated, Manual))), End User (CMO, Biopharmaceutical Company) – Global Forecast to 2025

https://www.marketsandmarkets.com/Market-Reports/fill-finish-manufacturing-market-6249609.html

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Ashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

sales@marketsandmarkets.com

Content Source: https://www.marketsandmarkets.com/PressReleases/prefilled-syringes.asp

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/prefilled-syringes-market.asp

Create a free website or blog at WordPress.com.

Up ↑

Create your website with WordPress.com
Get started